| 000 | 01786 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515040805.0 | ||
| 264 | 0 | _c20070119 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a1366-5278 | ||
| 024 | 7 |
_a10.3310/hta10320 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCastelnuovo, E | |
| 245 | 0 | 0 |
_aThe cost-effectiveness of testing for hepatitis C in former injecting drug users. _h[electronic resource] |
| 260 |
_bHealth technology assessment (Winchester, England) _cSep 2006 |
||
| 300 |
_aiii-iv, ix-xii, 1-93 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xprevention & control |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDecision Support Techniques |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFamily Practice |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 |
_aHepatitis C _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xprevention & control |
| 650 | 0 | 4 |
_aLiver Neoplasms _xprevention & control |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrisons |
| 650 | 0 | 4 | _aQuality-Adjusted Life Years |
| 650 | 0 | 4 | _aSubstance Abuse Treatment Centers |
| 650 | 0 | 4 |
_aSubstance Abuse, Intravenous _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aThompson-Coon, J | |
| 700 | 1 | _aPitt, M | |
| 700 | 1 | _aCramp, M | |
| 700 | 1 | _aSiebert, U | |
| 700 | 1 | _aPrice, A | |
| 700 | 1 | _aStein, K | |
| 773 | 0 |
_tHealth technology assessment (Winchester, England) _gvol. 10 _gno. 32 _gp. iii-iv, ix-xii, 1-93 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3310/hta10320 _zAvailable from publisher's website |
| 999 |
_c16532958 _d16532958 |
||